Update on biologics in psoriasis

被引：0

作者：

Chan, Y. ^{[1
]}

Yeung, K. H. ^{[1
]}

机构：

[1] Social Hyg Serv, Dept Hlth, Hong Kong, Hong Kong, Peoples R China

来源：

HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY | 2014年 / 22卷 / 01期

关键词：

Biologics; psoriasis; LONG-TERM EFFICACY; TO-SEVERE PSORIASIS; PLAQUE PSORIASIS; MODERATE; TUBERCULOSIS; ETANERCEPT; ANTIBODIES; SAFETY; USTEKINUMAB; INFLIXIMAB;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Biologic therapy has emerged for more than a decade, providing a new alternative in treating moderate to severe psoriasis. There has been much research done and published for this relatively recent therapeutic option. An update on the use of biologics may help clarify some practical challenges in deciding the appropriate treatment for individual patients. This article aims to review the treatment decisions that need to be considered in prescribing biologics and their use in different patient groups with the latest evidence in this area.

引用

页码：12 / 19

页数：8

共 40 条

[1] Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].

Baert, F ;

Noman, M ;

Vermeire, S ;

Van Assche, G ;

D'Haens, G ;

Carbonez, A ;

Rutgeerts, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608

[2] Influence of neutralizing antibodies to adalimumab and infliximab on the treatment of psoriasis [J].

Bito, T. ;

Nishikawa, R. ;

Hatakeyama, M. ;

Kikusawa, A. ;

Kanki, H. ;

Nagai, H. ;

Sarayama, Y. ;

Ikeda, T. ;

Yoshizaki, H. ;

Seto, H. ;

Adachi, A. ;

Horikawa, T. ;

Oka, M. ;

Nishigori, C. .

BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (04) :922-929

[3]

Calzavara-Pinton PG, 2013, BRIT J DERMATOL, V169, P130, DOI 10.1111/bjd.12277

[4] The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C [J].

Chiu, H. -Y. ;

Chen, C. -H. ;

Wu, M. -S. ;

Cheng, Y. -P. ;

Tsai, T. -F. .

BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (06) :1295-1303

[5] Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort [J].

Dalaker, M. ;

Bonesronning, J. H. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (03) :277-282

[6] Prevalence of psoriasis in China: A population-based study in six cities [J].

Ding, Xiaolan ;

Wang, Tinglin ;

Shen, Yiwei ;

Wang, Xiaoyan ;

Zhou, Cheng ;

Tian, Shan ;

Liu, Ying ;

Peng, Guanghui ;

Zhou, June ;

Xue, Shuyi ;

Wang, Renli ;

Tang, Ying ;

Meng, Xuemei ;

Pei, Guangde ;

Bai, Yunhua ;

Liu, Qing ;

Li, Hang ;

Zhang, Jianzhong .

EUROPEAN JOURNAL OF DERMATOLOGY, 2012, 22 (05) :663-667

[7] National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents [J].

Doherty, Sean D. ;

Van Voorhees, Abby ;

Lebwohl, Mark G. ;

Korman, Neil J. ;

Young, Melodie S. ;

Hsu, Sylvia .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (02) :209-217

[8]

EMA, 2013, ENBR

[9]

FDA, 2013, STEL UST PRESCR INF

[10] Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial [J].

Gisondi, P. ;

Del Giglio, M. ;

Cotena, C. ;

Girolomoni, G. .

BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (06) :1345-1349

← 1 2 3 4 →